LA
TNDM icon

LVW Advisors’s Tandem Diabetes Care TNDM Stock Holding History

LVW Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,798
Closed -$281K – 324
2024
Q4 		$281K Buy
7,798
+944
+14% +$31.9K 0.03% 260
2024
Q3 		$291K Sell
6,854
-1,015
-13% -$43K 0.04% 247
2024
Q2 		$317K Buy
7,869
+1,034
+15% +$43.1K 0.05% 223
2024
Q1 		$242K Buy
+6,835
New +$183K 0.04% 258
2022
Q2 		– Sell
-1,782
Closed -$207K – 248
2022
Q1 		$207K Buy
1,782
+90
+5% +$10.5K 0.04% 226
2021
Q4 		$255K Buy
+1,692
New +$228K 0.04% 212

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LVW Advisors's TNDM Position: Q1 2025 in Review

LVW Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 7,798 shares — an estimated $281K sold.

LVW Advisors first reported a position in TNDM in Q4 2021 and held it in 6 quarters. The position peaked at $317K in Q2 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • LVW Advisors reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • LVW Advisors sold 7,798 Tandem Diabetes Care shares in Q1 2025, an estimated $281K.
  • LVW Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 6 quarters.
  • LVW Advisors's Tandem Diabetes Care position peaked at $317K in Q2 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on LVW Advisors's 13F filing for Q1 2025, filed 9 Apr 2025.